This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (81) Citing Articles via Google Scholar Google Scholar Articles by Bavry, A. A. Articles by Bhatt, D. L. Search for Related Content PubMed PubMed Citation Articles by Bavry, A. A. Articles by Bhatt, D. L.

What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?

A meta-analysis

Anthony A. Bavry, MD, MPH^*, Dharam J. Kumbhani, MD, SM, Thomas J. Helton, DO^* and Deepak L. Bhatt, MD^*,*

^* Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
Department of Cardiac Surgery, Veterans Administration Boston Healthcare System, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

View larger version (32K): [in a new window]   Figure 1 In trials with varying doses of paclitaxel, a = 1.3, b = 3.1, A = 0.2, B = 0.7, C = 1.4, and D = 2.7 µg paclitaxel/mm2 of stent. BMS = bare-metal stent; CI = confidence interval; DES = drug-eluting stent; MR = moderate-release; SR = slow-release.